Latest News and Press Releases

EL SEGUNDO, Calif., and LONGMONT, Colo., March 13, 2003 (PRIMEZONE) -- Hauser, Inc. (OTCBB:HAUS) today said that, in the company description of its fiscal 2003 third quarter news release dated...

LONDON, March 3, 2003 (PRIMEZONE) -- Amersham Health, the global leader in medical diagnostic imaging and a business of Amersham plc (LSE:AHM) (NYSE:AHM) (Oslo:AHM) today announced that Finland's...

HOERSHOLM, Denmark, Jan. 29, 2003 (PRIMEZONE) -- As first announced on September 10, 2002, Pharmexa (Other OTC:PMXAY) is increasingly focusing its resources on the most advanced products, the HER-2...

BASEL, Switzerland and KUNDL, Austria, Jan. 21, 2002 (PRIMEZONE) -- Novartis (NYSE:NVS) today unveiled plans to unite its 14 Generics company brands under a single global umbrella name, "Sandoz," to...

HUDDINGE, Sweden, Sept. 30, 2002 (PRIMEZONE) -- Medivir's (Stockholm:MVIRb) antiviral MIV-210 is active against HIV and HBV (hepatitis B virus, viral jaundice) and is in phase I clinical trials. The...

ARNHEM, The Netherlands, Sept. 20, 2002 (PRIMEZONE) -- Akzo Nobel (Nasdaq:AKZOY) has divested Rosemont Pharmaceuticals Ltd. of Leeds, United Kingdom, its liquid pharmaceuticals manufacturing business...

BERLIN, Germany, Sept. 17, 2002 (PRIMEZONE) -- atugen AG today announced a new collaboration with Schering AG (Frankfurt:SCHG) (NYSE:SHR) to validate a number of novel drug targets associated with...

CAMBRIDGE, U.K., Sept. 4, 2002 (PRIMEZONE) -- Astex Technology, the structure-based drug discovery company, today announced that it has received the first milestone payment from Aventis...

HORSHOLM, Denmark, Aug. 21, 2002 (PRIMEZONE) -- The Pharmexa Group had turnover of kDKK 8,123 in the first 6 months of 2002 and realized a net loss of kDKK 75,519. Research and Development costs...

RANCHO SANTA MARGARITA, Calif., July 24, 2002 (PRIMEZONE) - BioCurex (OTCBB:BOCX) announces another important distribution deal for its novel cancer diagnostic kits. P2000 Comercializacao de...